Alleviation of metabolic dysfunction-associated steatotic liver disease by silymarin is associated with maintaining mitochondrial homeostasis via regulation of optic atrophy 1.

已完结 10 由 459 发布于 2026/7/15 13:08:31

DOI:10.1016/j.jpet.2025.103611
作者：Ming-Qiang Liu,?Yuan Wu,?Ye Li,?Yan-Bo Wei,?Ling-Yue Dong,?Wei An
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1016/j.jpet.2025.103611

Elsevier

Abstract：Silibinin (silybin) is the major active compound of silymarin used to treat several chronic liver diseases including metabolic dysfunction-associated steatotic liver disease (MASLD). However

应助信息

6小时前

小丹

202607151700206548178.pdf 已采纳

9小时前

Book学术机器人

2026/7/15 13:08:31 未找到该文献，机器人已退出，请等待人工下载

2026/7/15 13:08:31 Book学术AI机器人收到请求，开始寻找文献

2026/7/15 13:08:31 已向机器人发送请求

9小时前

459 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierExosome-targeted injectable hydrogels for sustained DEPTOR delivery and delay of IDD via the mTORC1/SASP pathway